Insider Selling: Colgate-Palmolive Company (CL) Vice Chairman Sells 35,000 Shares of Stock

Colgate-Palmolive Company (NYSE:CL) Vice Chairman Franck J. Moison sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $71.52, for a total value of $2,503,200.00. Following the transaction, the insider now owns 201,411 shares of the company’s stock, valued at approximately $14,404,914.72. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Colgate-Palmolive Company (CL) opened at 71.02 on Friday. The company has a market capitalization of $62.56 billion, a PE ratio of 26.39 and a beta of 0.80. The firm’s 50-day moving average price is $72.30 and its 200 day moving average price is $72.91. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the consensus estimate of $0.72. The business had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The firm’s revenue for the quarter was down .5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.70 earnings per share. Equities analysts predict that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. The ex-dividend date was Friday, July 14th. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.

TRADEMARK VIOLATION NOTICE: This report was first published by BNB Daily and is the sole property of of BNB Daily. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/colgate-palmolive-company-cl-vice-chairman-sells-2503200-00-in-stock-updated.html.

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after buying an additional 1,621,392 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Colgate-Palmolive by 0.9% in the first quarter. Bank of New York Mellon Corp now owns 18,821,363 shares of the company’s stock valued at $1,377,537,000 after buying an additional 169,798 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after buying an additional 2,903,800 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of Colgate-Palmolive by 25.3% in the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after buying an additional 1,385,946 shares in the last quarter. Finally, First Eagle Investment Management LLC boosted its position in shares of Colgate-Palmolive by 2.3% in the second quarter. First Eagle Investment Management LLC now owns 4,891,131 shares of the company’s stock valued at $362,580,000 after buying an additional 108,850 shares in the last quarter. Institutional investors own 73.69% of the company’s stock.

Several research firms have recently commented on CL. Bank of America Corporation lifted their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. BidaskClub cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Vetr cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research note on Wednesday, May 17th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Finally, Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Tuesday, July 4th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $75.82.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply